Improvements in skeletal manifestations in Gaucher disease type 1 patients after 3 years of treatment with oral eliglustat during a phase 2 trial

Authors
Category Primary study
JournalBlood
Year 2011
This article has no abstract
Epistemonikos ID: da14acb91a759a189d7d6747199e76f062227f2f
First added on: Feb 05, 2025